FIELD: medicine.
SUBSTANCE: for treating experimental myocardial infarction in rats, after modeling myocardial infarction, L-17 compound of 1,3,4-thiadiazine class is injected intravenously.
EFFECT: effective treatment ensured by ability of said compound to reduce an inflammation, to intensify a fibroplastic reaction and vascularisation.
2 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING EXPERIMENTAL MYOCARDIAL INFRACTION IN RATS | 2010 |
|
RU2437163C1 |
METHOD OF IMMUNE CORRECTOR THERAPY OF MYOCARDIAL INFRACTION IN RATS | 2010 |
|
RU2437165C1 |
METHOD OF TREATING EXPERIMENTAL PANCREATONECROSIS | 2012 |
|
RU2525015C2 |
METHOD OF TREATING PANCREONECROSIS | 2011 |
|
RU2492527C2 |
METHOD OF MODELING MYOCARDIAL INFARCTION IN RATS | 2007 |
|
RU2407062C2 |
METHOD OF CREATING EXPERIMENTAL MODEL OF PANCREATIC NECROSIS IN RATS | 2008 |
|
RU2400820C2 |
METHOD FOR SIMULATION OF PANCREONECROSIS IN RATS | 2007 |
|
RU2388063C2 |
METHOD FOR SURGICAL TREATMENT OF TRAUMATIC SPLENIC LESIONS WITH HYALURONIC ACID-BASED FILM | 2003 |
|
RU2258517C1 |
METHOD FOR PREDICTION OF POSTOPERATIVE COMPLICATIONS AFTER HERNIOTOMY IN DISTANT POST-OPERATIVE PERIOD | 2016 |
|
RU2644938C1 |
MEDICINE FOR STIMULATION OF WOUND REPARATIVE PROCESSES | 2008 |
|
RU2369395C1 |
Authors
Dates
2010-07-27—Published
2008-06-23—Filed